Northwestern University has entered the growing longevity market by offering an annual assessment package priced at $5,500, a move that has drawn scrutiny regarding the compatibility of high out-of-pocket costs with the institution's nonprofit status. The clinic, which operates under the university's health system, provides patients with detailed evaluations of their physical condition and aging trajectories, aiming to offer a scientific alternative to typical doctor's visits.
The comprehensive package includes a VO2 Max test, a procedure designed to measure how efficiently the body uses oxygen. Considered medicine's most accurate measure of cardiorespiratory fitness, the test requires patients to exercise on a treadmill while wearing a mask that collects breath samples. During the assessment, patients are monitored as they increase their exertion levels, with the goal of reaching maximum physical capacity. This rigorous testing forms part of a broader suite of assessments intended to provide a detailed picture of a patient's current health and potential aging path.
The entry of prestigious health systems like Northwestern into the longevity sector marks a significant shift in how some institutions approach the prevention of age-related decline. These clinics promise to help patients preserve youthful vigor through a rigorous scientific approach, distinguishing themselves from historical and often questionable anti-aging practices. Such earlier methods included the use of grafted monkey testicles in the 1920s and Bryan Johnson's abandoned blood transfusions from his teenage son. By contrast, the new clinics emphasize data-driven assessments that offer more granular insights than standard medical checkups.
However, the expansion of longevity services into major nonprofit hospitals has raised concerns among critics. Questions have been raised about how to reconcile the substantial costs charged to patients with the charitable missions and nonprofit status of these health systems. Furthermore, some observers warn that in the effort to attract paying customers, these clinics may be offering tests that lack sufficient evidence demonstrating they actually improve people's health. The debate centers on whether the financial models and medical claims of these new programs align with the ethical obligations of academic medical centers.